Merck & Co., Inc. Income (Loss) from Equity Method Investments
Merck & Co., Inc. (MRK) reported Income (Loss) from Equity Method Investments of $81.00 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2018-11-06
- Merck & Co., Inc. income (loss) from equity method investments for the quarter ending 2018-09-30 was $81.00M, a 350.00% increase year-over-year.
- Merck & Co., Inc. income (loss) from equity method investments for the quarter ending 2018-06-30 was $64.00M, a 1180.00% increase year-over-year.
- Merck & Co., Inc. income (loss) from equity method investments for the quarter ending 2018-03-31 was -$52.00M.
- Merck & Co., Inc. income (loss) from equity method investments for the quarter ending 2017-12-31 was $31.00M, a 14.81% increase year-over-year.
- Merck & Co., Inc. income (loss) from equity method investments for fiscal 2017 was $42.00M, a 51.16% decline from fiscal 2016.
- Merck & Co., Inc. income (loss) from equity method investments for fiscal 2016 was $86.00M, a 58.05% decline from fiscal 2015.
- Merck & Co., Inc. income (loss) from equity method investments for fiscal 2015 was $205.00M, a 20.23% decline from fiscal 2014.
- Merck & Co., Inc. income (loss) from equity method investments for fiscal 2014 was $257.00M, a 36.39% decline from fiscal 2013.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 9 month as first filed | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $81.00M 10-Q · filed 2018-11-06 | $145.00M derived: sum of 2 quarters · filed 2018-11-06 | $93.00M 10-Q · filed 2018-11-06 | $124.00M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2018-06-30 | $64.00M 10-Q · filed 2018-08-07 | $12.00M 10-Q · filed 2018-08-07 | $43.00M derived: sum of 3 quarters · filed 2018-08-07 | $61.00M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2018-03-31 | -$52.00M 10-Q · filed 2018-05-08 | -$21.00M derived: sum of 2 quarters · filed 2018-05-08 | -$3.00M derived: sum of 3 quarters · filed 2018-11-06 | $2.00M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $49.00M derived: sum of 2 quarters · filed 2018-11-06 | $54.00M derived: sum of 3 quarters · filed 2018-11-06 | $42.00M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $18.00M 10-Q · filed 2018-11-06 | $23.00M derived: sum of 2 quarters · filed 2018-11-06 | $11.00M 10-Q · filed 2018-11-06 | $37.00M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-06-30 | $5.00M 10-Q · filed 2018-08-07 | -$8.00M 10-Q · filed 2018-08-07 | $19.00M derived: sum of 3 quarters · filed 2018-08-07 | $40.00M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | -$13.00M 10-Q · filed 2018-05-08 | $14.00M derived: sum of 2 quarters · filed 2018-05-08 | $35.00M derived: sum of 3 quarters · filed 2018-05-08 | $39.00M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $48.00M derived: sum of 2 quarters · filed 2018-02-27 | $52.00M derived: sum of 3 quarters · filed 2018-02-27 | $86.00M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $21.00M 10-Q · filed 2017-11-07 | $25.00M derived: sum of 2 quarters · filed 2017-11-07 | $59.00M 10-Q · filed 2017-11-07 | $54.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $4.00M 10-Q · filed 2017-08-08 | $38.00M 10-Q · filed 2017-08-08 | $33.00M derived: sum of 3 quarters · filed 2018-02-27 | $96.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $34.00M 10-Q · filed 2017-05-09 | $29.00M derived: sum of 2 quarters · filed 2018-02-27 | $92.00M derived: sum of 3 quarters · filed 2018-02-27 | $94.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $58.00M derived: sum of 2 quarters · filed 2018-02-27 | $60.00M derived: sum of 3 quarters · filed 2018-02-27 | $205.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $63.00M 10-Q · filed 2016-11-07 | $65.00M derived: sum of 2 quarters · filed 2016-11-07 | $210.00M 10-Q · filed 2016-11-07 | $226.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $2.00M 10-Q · filed 2016-08-08 | $147.00M 10-Q · filed 2016-08-08 | $163.00M derived: sum of 3 quarters · filed 2017-02-28 | $187.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $145.00M 10-Q · filed 2016-05-09 | $161.00M derived: sum of 2 quarters · filed 2017-02-28 | $185.00M derived: sum of 3 quarters · filed 2017-02-28 | $277.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $40.00M derived: sum of 2 quarters · filed 2017-02-28 | $132.00M derived: sum of 3 quarters · filed 2017-02-28 | $257.00M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $24.00M 10-Q · filed 2015-11-05 | $116.00M derived: sum of 2 quarters · filed 2015-11-05 | $241.00M 10-Q · filed 2015-11-05 | $293.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $92.00M 10-Q · filed 2015-08-06 | $217.00M 10-Q · filed 2015-08-06 | $269.00M derived: sum of 3 quarters · filed 2016-02-26 | $371.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $124.00M 10-Q · filed 2015-05-07 | $177.00M derived: sum of 2 quarters · filed 2016-02-26 | $279.00M derived: sum of 3 quarters · filed 2016-02-26 | $395.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $155.00M derived: sum of 2 quarters · filed 2016-02-26 | $271.00M derived: sum of 3 quarters · filed 2016-02-26 | $404.00M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $102.00M 10-Q · filed 2014-11-10 | $218.00M derived: sum of 2 quarters · filed 2014-11-10 | $351.00M 10-Q · filed 2014-11-10 | $583.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $116.00M 10-Q · filed 2014-08-07 | $249.00M 10-Q · filed 2014-08-07 | $481.00M derived: sum of 3 quarters · filed 2015-02-27 | $639.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $133.00M 10-Q · filed 2014-05-08 | $365.00M derived: sum of 2 quarters · filed 2015-02-27 | $523.00M derived: sum of 3 quarters · filed 2015-02-27 | $665.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $232.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $390.00M derived: sum of 2 quarters · filed 2015-02-27 | $532.00M derived: sum of 3 quarters · filed 2015-02-27 | $642.00M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $158.00M 10-Q · filed 2013-11-07 | $300.00M derived: sum of 2 quarters · filed 2013-11-07 | $410.00M 10-Q · filed 2013-11-07 | $666.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $142.00M 10-Q · filed 2013-08-07 | $253.00M 10-Q · filed 2013-08-07 | $508.00M derived: sum of 3 quarters · filed 2014-02-27 | $669.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $110.00M 10-Q · filed 2013-05-09 | $366.00M derived: sum of 2 quarters · filed 2014-02-27 | $527.00M derived: sum of 3 quarters · filed 2014-02-27 | $582.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $256.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $417.00M derived: sum of 2 quarters · filed 2014-02-27 | $472.00M derived: sum of 3 quarters · filed 2014-02-27 | $610.00M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $161.00M 10-Q · filed 2012-11-09 | $216.00M derived: sum of 2 quarters · filed 2012-11-09 | $354.00M 10-Q · filed 2012-11-09 | $524.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $55.00M 10-Q · filed 2012-08-07 | $193.00M 10-Q · filed 2012-08-07 | $363.00M derived: sum of 3 quarters · filed 2013-02-28 | $599.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $138.00M 10-Q · filed 2012-05-08 | $308.00M derived: sum of 2 quarters · filed 2013-02-28 | $544.00M derived: sum of 3 quarters · filed 2013-02-28 | $587.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $170.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $406.00M derived: sum of 2 quarters · filed 2013-02-28 | $449.00M derived: sum of 3 quarters · filed 2013-02-28 | $587.00M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $236.00M 10-Q · filed 2011-11-08 | $236.40M 10-Q · filed 2010-11-08 | $279.00M derived: sum of 2 quarters · filed 2011-11-08 | $417.00M 10-Q · filed 2011-11-08 | $416.80M 10-Q · filed 2010-11-08 | $790.80M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | $43.00M 10-Q · filed 2011-08-08 | $42.90M 10-Q · filed 2010-08-06 | $180.00M 10-Q · filed 2011-08-08 | $180.40M 10-Q · filed 2010-08-06 | $554.80M derived: sum of 3 quarters · filed 2012-02-28 | $1.24B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | $138.00M 10-Q · filed 2011-05-09 | $137.50M 10-Q · filed 2010-05-07 | $511.80M derived: sum of 2 quarters · filed 2012-02-28 | $1.20B derived: sum of 3 quarters · filed 2012-02-28 | $1.79B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $373.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.06B derived: sum of 2 quarters · filed 2012-02-28 | $1.65B derived: sum of 3 quarters · filed 2012-02-28 | $2.23B 10-K · filed 2012-02-28 | ||||
| 2009-09-30 | $688.20M 10-Q · filed 2010-11-08 | $387.00M 10-Q · filed 2009-10-29 | $1.28B derived: sum of 2 quarters · filed 2010-11-08 | $1.86B 10-Q · filed 2010-11-08 | $1.16B 10-Q · filed 2009-10-29 | $2.98B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-06-30 | $587.10M 10-Q · filed 2010-08-06 | $370.00M 10-Q · filed 2009-07-24 | $1.17B 10-Q · filed 2010-08-06 | $770.00M 10-Q · filed 2009-07-24 | $2.29B derived: sum of 3 quarters · filed 2011-02-28 | $2.72B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-03-31 | $585.80M 10-Q · filed 2010-05-07 | $1.70B derived: sum of 2 quarters · filed 2011-02-28 | $2.14B derived: sum of 3 quarters · filed 2011-02-28 | $2.63B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $1.55B derived: sum of 2 quarters · filed 2011-02-28 | $2.04B derived: sum of 3 quarters · filed 2011-02-28 | $2.56B 10-K · filed 2011-02-28 | $2.56B 10-K · filed 2010-03-01 | |||
| 2008-09-30 | $434.00M 10-Q · filed 2009-10-29 | $927.00M derived: sum of 2 quarters · filed 2009-10-29 | $1.44B 10-Q · filed 2009-10-29 | |||||
| 2008-06-30 | $493.00M 10-Q · filed 2009-07-24 | $1.01B 10-Q · filed 2009-07-24 | ||||||
| 2007-12-31 | $2.98B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |